Author

Hao-Wen Lv

h-index 1 View on Semantic Scholar

We have 2 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Sep 2026

Adjuvant immunotherapy versus observation after neoadjuvant therapy and esophagectomy for esophageal cancer with residual pathologic disease: a systematic review and reconstructed individual participant data meta-analysis

Background The role of adjuvant immunotherapy after neoadjuvant therapy and esophagectomy remains uncertain. We examined its association with survival in populations composed predominantly of patients with residual disease across neoadjuvant strategies. Methods This systematic review included comparative studies of pos...

Hong-Zhi He, Han-Lu Zhang, Hao-Wen Lv et al. · Frontiers in Immunology · 0 citations

Review Open access Jul 2026

Comparative efficacy and outcomes of different treatments for pathologically high-risk superficial esophageal cancer: a systematic review and network meta-analysis

ER followed by chemoradiotherapy may represent a clinically relevant organ-preserving strategy, particularly for patients in whom esophagectomy is not preferred or feasible, and may support ER+ESO as an important post-ER treatment option when surgical tolerance is acceptable.

Hong-Zhi He, Han-Lu Zhang, Hao-Wen Lv et al. · Frontiers in Oncology · 0 citations